tirzepatide nutrition recommendations foods to avoid: the complete guide to eating smarter on GLP-1 therapy GLP-1 drugs such as semaglutide

FDA-approved weight loss medications (semaglutide and tirzepatide) require either a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia

Regulatory bodies across multiple regions have approved semaglutide for diabetes and weight management, reflecting robust clinical evidence

This means that if you take semaglutide for a year or more, you may experience up to 15% total weight loss weight-which is great news for those looking for long-term results from their weight loss efforts

Oral bioavailability for systemic purposes is estimated at 1030% of injectable delivery

Once you drop below that range, metabolism may actually slow in an attempt to move you closer to the set point

These supplements are banned by many sporting regulatory agencies